Developing biomarkers to monitor menopause in women
Official title: Development of Biomarkers for Monitoring Menopause in Women
Run by Fu Jen Catholic University Hospital · NCT06852755 · Data updated 2026-11-12
This study is trying to find new blood markers that can help track menopause in women by looking at different stages of their reproductive health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Fu Jen Catholic University Hospital Academic / other |
| Locations | 1 site (New Taipei City) |
| Status | Recruiting |
| Started | July 30, 2024 |
| Main results expected | February 2026 |
| Study ends | August 2026 |
| Registry record updated | May 25, 2025 |
| Trial ID | NCT06852755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are biological females aged 20 years and older who are in different stages of menopause.
✕Probably not a fit
Patients with cancer, acute or chronic infections, known chronic illnesses, or those undergoing female hormone therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women by analyzing peripheral blood samples from 100 participants across three groups: reproductive, perimenopausal, and postmenopausal. The study will utilize both qualitative and quantitative analyses to assess mitochondrial quality and quantity, identifying potential biomarkers through metabolomics. This innovative approach seeks to address unmet needs in women's health management during menopause, particularly in monitoring psychological changes and systemic health issues associated with this transition.
Why it matters
Potential benefit: If successful, this study could provide a novel monitoring system for women's health during menopause, improving management of associated conditions.
How similar studies have gone: While there have been studies focusing on menopausal symptoms, the specific approach of developing mitochondrial biomarkers for monitoring menopause is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological female, age order than 20 years old. Exclusion Criteria: * Person with cancer. * Person with any known acute or chronic infection. * Person with known chronic illness under follow up or treatment. * Pregnancy, one year withing delivery, under breast feeding, or three months within breast feeding. * Under any female horemone therapy.
Where it's running
-
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, Taiwan Recruiting
Study contacts
- Study coordinator: Shu-Yu Liu
- Email: syliu0123@outlook.com
- Phone: +886910893512
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.